Skip to content

Datavant Completes Acquisition of Aetion.   Learn more → 

Evidence Hub

Feb 14, 2023

Frequency of opioid dispensing after vaginal delivery

Objective: To describe nationwide patterns in outpatient opioid dispensing after vaginal ...
Start Reading
Feb 8, 2023

Research spotlight: RWD transferability across borders

Manufacturers are increasingly using real-world data (RWD) to generate real-world ...
Start Reading
Feb 5, 2023

Synthetic Data is Key to Privacy by Design Practices in New Canadian Smart City Partnership

This article by the International Association of Privacy Professionals covers the ...
Start Reading
Feb 5, 2023

Accelerating AI with Synthetic Data

This book published by O'Reilly focuses on advancements in generating high-quality ...
Start Reading
Feb 5, 2023

Discussion with Dr. Khaled El Emam on synthetic data

In this podcast, called Unredacted, Replica Analytics’ SVP & GM, Khaled El Emam, is ...
Start Reading
Feb 5, 2023

Real or Fake? The Buzz About Synthetic Data

In this podcast on InfoMatters, Replica Analytics’ SVP & GM, Khaled El Emam, is ...
Start Reading
Feb 5, 2023

Precaution, Ethics & Risk: Perspectives on Regulating Non-identifiable Data

This article published by the International Association of Privacy Professionals delves ...
Start Reading
Feb 5, 2023

Deciphering Deep Fakes & Synthetic Data

In a podcast on ThatTechPod, Khaled El Emam, SVP & GM of Replica Analytics discusses ...
Start Reading
Feb 5, 2023

Replica Analytics Using Synthetic Data to Ease Medical Researchers’ Pain

This article in Ottawa Business Journal provides some background on Replica Analytics as ...
Start Reading
Feb 5, 2023

10 Recommendations for Regulating Non-identifiable Data

This article published by the International Association of Privacy Professionals outlines ...
Start Reading
Feb 5, 2023

CityAge Q&A with Khaled El Emam

This Q&A is published by CityAge. Replica Analytics’ SVP & GM, Khaled El Emam, ...
Start Reading
Feb 5, 2023

Enabling Health Information Sharing with Synthetic Data

This article in Privacy Laws & Business discusses the surging demand for access to ...
Start Reading
Feb 5, 2023

Privacy Tech Talk: May 18, 2022

This podcast on PrivacyTechTalk focuses on synthetic data generation, which is gaining ...
Start Reading
Feb 5, 2023

Real-World Evidence Firm Aetion Grabs Privacy-Protected Synthetic Data Provider Replica Analytics

This article from Fierce Healthcare reports on Aetion's acquisition of Replica Analytics, ...
Start Reading
Feb 5, 2023

Synthetic Data Paradigm for Using and Sharing Data

This article published by Cutter provides an overview of the use cases for synthetic ...
Start Reading
Feb 3, 2023

A Solution for Payers to Use Real World Evidence in Pharma Confidently

Tackling three common concerns
Start Reading
Feb 1, 2023

What is synthetic data and how is it generated?

By Khaled El Emam | Published: February, 2023 The following article was published by ...
Start Reading
Jan 27, 2023

Changing the Conversation on Privacy – Using Data For Good

Start Reading
Jan 18, 2023

Generating and Evaluating Synthetic Clinical Trial Data in a Pharmaceutical Company

Start Reading
Jan 18, 2023

A review of the new ISO Standard on Data De-identification: ISO/IEC 27559

Start Reading
Jan 17, 2023

RWE Meaning | Update: What the Omnibus FDA Amendments Mean for RWE

On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023, a ...
Start Reading
Dec 20, 2022

Replica Analytics Top 10 Round-up for 2022

By Replica staff
Start Reading
Dec 1, 2022

Evaluating Privacy Risks in Synthetic Data Using Membership Disclosure

Start Reading
Nov 1, 2022

Synthetic data as an enabler for machine learning applications in medicine

Start Reading